Semin Respir Crit Care Med 2003; 24(2): 229-230
DOI: 10.1055/s-2003-39023
ERRATA

Copyright © 2003 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New York, NY 10001, USA. Tel.: +1(212) 584-4662

Leukotriene Receptor Antagonists

Marzena E. Krawiec1 , Nizar  J. Jarjour2
  • 1Department of Pediatrics, University of Wisconsin, Madison, Wisconsin
  • 2Department of Medicine, University of Wisconsin, Madison, Wisconsin
Further Information

Publication History

Publication Date:
07 May 2003 (online)

The publisher regrets an error in a statement in the above article in Seminars in Respiratory and Critical Care Medicine, volume 23, number 4, p. 403. Column 1, paragraph 1. A sentence states: "Furthermore, urinary excretion of LTE4 was significantly increased in the montelukast group (34.4 to 73.7 pg/mg creatinine; p < 0.05) compared with placebo." It should say: "Furthermore, urinary excretion of LTE4 was significantly increased after exercise (34.4 to 73.7 pg/mg creatinine; p < 0.05)."